Global Blood Screening Market 2020 Astonishing Growth | Thermo Fisher Scientific Inc., BioM�rieux SA, Beckman Coulter

Blood screening market research report acts as a strong backbone for healthcare industry with which it can outdo the competition. This report not only offers actionable market insights but also lend a hand to create sustainable and money-spinning business strategies. This report has a lot of features to offer about the healthcare industry such as the general market conditions, trends, inclinations, key players, opportunities, and geographical analysis. Furthermore, this comprehensive blood screening report offers better market perspective in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviours.

Blood screening market is expected to reach a healthy CAGR of 9.7% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Download Sample PDF Copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-blood-screening-market&PM

Competitive Analysis:

Some of the prominent participants operating in this market are Enzo Biochem Inc., Meridian Bioscience, Inc. , BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc., BioM�rieux SA, Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc., among others.

Segmentation: Global Blood Screening Market

By Products & Services

(Reagents & Kits, Instruments, Software & Services),

Technology

(Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others),

Disease Type

(Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others),

End User

(Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers),

Geography

(North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Drivers: Global Blood Screening Market

RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS:

Blood transfusion is an essential component of the health care field. It helps in saving millions of lives every year in both cases of routine and emergency conditions. Below mentioned are some of the statistics for blood donation and blood donors:

According to the World Health Organization (WHO), in 2017, it was reported that 112.5 million blood donations were collected from worldwide in which approximately half of the blood was collected from developed countries.

According to the World Health Organization (WHO), in 2017, it was reported that in 1000 people, the blood donation rate was 32.1 from high-income countries, 14.9 in upper-middle-income countries, 7.8 in lower-middle-income countries and 4.6 in low-income countries.

According to Australia Red cross blood service, 606,000 donors are there in Australia which are in 1,000 locations such as collection centres for blood donation available.

Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-blood-screening-market&PM

Restraints:

LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES

Nucleic acid amplification technology (NAT) is helpful in determining safety and efficiency of mini-pool testing for various health related problems such as hepatitis C virus (HCV), human immunodeficiency virus (HIV) and other diseases.

In June 2014, a paper published by National Center for Biotechnology Information (NCBI), NAT is one of the advanced techniques, highly sensitive and has issues of high cost related to an infrastructure facility, equipment, consumables lacking in technical expertise for developing countries.

In April 2018, article published by Indian Journal of Pathology and Microbiology, in India, 10 � 10^6 units of blood collected every year. If the whole collected blood is NAT tested then the country will experience an additional cost of 30 � 10^7. The 3 � 10^8 means 300 million US dollar which is a much higher amount for the developing country to afford.

HIGH COST OF TECHNOLOGY AND INSTRUMENTS

A blood screening is a process where blood is tested to detect particular disease in humans. This screening process is carried out in clinical diagnostics specifically for the detection of diseases such as HIV, infection and many other problems related to human health.

Several equipments used such as immunoassay analyzers, chemistry analyzers, assay kits, andhaematology analyzers for the detection of various blood screening process. Specialized analyzers are used to perform assays which are less commonly performed. Typically assay kits are used as standard lab equipments such as a spectrophotometer, and other equipments for ELISA process. Blood Screening Instruments have high cost and also requires maintenance after some period of time.

Merck KGaA (Germany) provides Acetate Colorimetric Assay Kit can be used for 100 colorimetric tests cost for USD 560.615 dollar which is costly to perform tests in laboratory in low income countries. This test is useful for detection of acetate in serum, plasma and animal tissues.

Inquire Regarding This Report https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-blood-screening-market&PM

Opportunity: Global Blood Screening Market

INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING

The screening of blood involves the process that ensures whether the blood collected from people are safe or not. Based on the results of the screening, collected blood units are released for clinical research purpose or discarded if it has some contamination of bacteria or viruses or any other. For performing such screening there are different assays that help in determining the proper result.

Further with advancement, many of the other techniques are introduced with high benefits helping the market to grow in the upcoming days. The techniques are microbial screening and multiplexing technology.

Thermo Fisher Scientific (U.S.) provides microbial isolation and screening which include blood culture systems, clinical microbial identification, and microbiology specimen collection

In August 2015, Eurofins (France) launched accredited NGS tests useful for the identification of non-targeted microorganism. It helps in 16S rDNA screening for identifying the presence of microorganism communities in sample.

In July 2017, July 18, 2017-BD (Becton, Dickinson and Company) (U.S.) introduced new technologies which can automatically report and release negative urine cultures. This technology is transformed in the form of microbiology urine testing.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.